Elekta B Shs (EKTAF) 13.4363 $EKTAF
Elekta Nomination Committee's proposed Board of Directors for 2014 Annual General Meeting
Business Wire - 55 mins ago
Regulatory News:
Global Laboratory Information Systems (LIS / LIMS) Market 2017 - Clinical Laboratory Software and Hardware, Drug Discovery Systems
M2 - Wed Apr 16, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/644b9v/laboratory) has announced the addition of the "Laboratory Information Systems (LIS / LIMS) Markets - Clinical Laboratory Software and Hardware, Drug Discovery Systems" report to their offering. The market for laboratory information management systems will grow to nearly a $1.5 billion market in 2015. The healthcare market research firm said growth would be spurred on by the desire of clinical diagnostic laboratories to handle larger amounts of data from molecular testing and sequencing. Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories. The World Market for Lab Information Systems (LIS) analyzes the current and potential world markets for medical laboratory information system software and hardware - both for the clinical diagnostics lab and the drug discovery and research laboratory. This report forecasts future growth to 2017. Market segments covered include the world, North American, European, Brazilian and Japanese markets, as well as segments for LIS software and hardware. As part of its coverage, the report contains the following: - Clinical LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Drug Discovery LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Recent Key Mergers and Acquisitions - Laboratory Types and Growth - Laboratory Information Systems Selected Vendors, Approximate Number of Contracts/Operating Sites - Software Markets - Hardware Markets - Service Markets - Drivers and Obstacles to Growth This report also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. Among these trends are the following: - Accelrys Acquires Aegis, Vialis - Roper Acquires Sunquest - StarLims Acquires Distributors - On-Demand LIMS - Toxicology LIS - HIPAA 5010 Migration - Multi-Groups Capability - Middleware Platform - Cerner Expands with Labotix Acquisition - Next-Generation Sequencing - Proof of Concept Service Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Trends And Issues Chapter Four: Recent Market Developments Chapter Five: Markets Chapter Six: Corporate Profiles - AAC Infotray AG - Accelrys Inc - Accelerated Technology Laboratories Inc - AJ Blomesystem GmbH - ASM Soft SL - Autoscribe - CambridgeSoft - Cerner Corp - ChemWare Inc - Clinical Software Solutions - Data Unlimited International Inc. - Desarrollo Aplicaciones Sanitarias SL - eBioSys Pty Ltd - Elekta AB - Kriti Microsystems Pvt. Ltd - LabLogic Systems Ltd - LabVantage Solutions Inc - LabWare Inc - LIMS at Work GmbH - McKesson Technology Solutions - Modul-Bio - Orchard Software Corp - PathCentral - Polisystem Informatica Srl - Siemens Healthcare - Swisslab GmbH - Tainosystems - Technidata - Thermo Fisher Scientific - Visual Access Health Systems Pvt. Ltd For more information visit http://www.researchandmarkets.com/research/644b9v/laboratory
Global Radiation Therapy Equipment Market 2014-2018: Key Regions, Key Vendors and Key Market Trends
M2 - Wed Mar 26, 5:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v2bjnr/global_radiation) has announced the addition of the "Global Radiation Therapy Equipment Market 2014-2018" report to their offering. Radiation therapy equipment is used to perform radiation therapy, also known as radiotherapy or radiation oncology, which is a procedure used in the treatment of cancer. It involves delivering high doses of radiation consisting of photons, electrons or gamma rays to kill cancer cells and reduce the rate at which the cancerous cells multiply by damaging the DNA inside the tumor cells. Radiation therapy is used to treat cancers of the head and neck, bladder, and lung as well as Hodgkin's disease. Radiation therapy can be administered in several ways. The type of therapy prescribed by oncologists depends on factors such as the type of cancer, the stage of the cancer, the size of the tumor, the position of the tumor in the body, the age of the patient, and the patient's medical history. Radiation therapy can either be given independently or in conjunction with other cancer treatments such as surgery and chemotherapy. The analysts forecast the Global Radiation Therapy Equipment market will grow at a CAGR of 6.04 percent over the period 2013-2018. Key Regions - Americas - EMEA - APAC Key Vendors - Accuray Inc. - Elekta AB - Siemens Healthcare - Varian Medical Systems Inc. Other Prominent Vendors - Best Theratronics Ltd. - Brainlab AG - C.R. Bard Inc. - Eckert & Ziegler BEBIG - GE Healthcare Ltd. - Hitachi America Ltd. - Ion Beam Applications SA - Philips Healthcare - RaySearch Laboratories AB Key Market Drivers - Increase in Aging Population. - For a full, detailed list, view our report. For more information visit http://www.researchandmarkets.com/research/v2..._radiation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Internal Beam & Systemic Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017
M2 - Wed Mar 12, 3:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t7wqw3/internal_beam_and) has announced the addition of the "Internal Beam & Systemic Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017" report to their offering. Rising cancer cases have made radiotherapy a standard procedure for oncology treatment. With a prominent rise in their GDP, emerging nations act as the future growth opportunities for the global radiotherapy market. Internal radiation therapy or brachytherapy is one of the oldest techniques for the treatment of cancerous tumors. As per the procedures, this process is categorized into permanent and temporary procedures where low dose rate and high dose rate brachytherapy are applied respectively. This report comprises of a holistic analysis of the market in terms of forces affecting the market. Its sub-components/forces include bargaining power of suppliers, bargaining power of buyers, threat of substitutes, threat of new entrants and competitive rivalry. The study analyzes the market for segments such as brachytherapy seeds, applicators and afterloaders and electronic brachytherapy along with their applications that include Prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, lung cancer, head and neck cancer and esophageal cancer. The study also analyzes four regions namely, North America, Europe, Asia-Pacific and Rest of the World for the Internal Beam Radiation Devices Market. The report elucidates several dynamics of the market such as the drivers, inhibitors, and opportunities that are illustrated throughout the report. It provides current and future outlook for the market on a global level as well as a focused view on independent sub-segments within the market. The report also profiles key market players Accuray Inc., Angiodynamics Inc., Boston Scientific Corporation, C.R. Bard, Cardinal Health Inc., Covidien PLC, GE Healthcare, Siemens Healthcare, Theragenics Corporation and others. The study provides a market share analysis for the year 2012 with respect to key players and also provides recent developments for all profiled companies. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics - Products Market Size & Forecast - Global Internal Beam Radiation Therapy Devices - Products Market Size & Forecast - Global Systemic Radiation Therapy Devices - Applications Market Size & Forecast - Global Internal Beam Radiation and Systemic Therapy Devices - Technology Market Size & Forecast - Global Internal Beam Radiation Therapy Devices - Geography Market Size & Forecast - Global Internal Beam & Systemic Radiation Therapy Devices - Competitive Scenario: Key Players - Company Profiles Companies Mentioned - Boston Scientific - C.R. Bard - Eckert & Ziegler BEBIG - Elekta AB - GE Healthcare - IBA - Nordion - Theragenics - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/t7...l_beam_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Elekta reports number of share
M2 - Mon Mar 03, 4:26AM CST
Human care company Elekta AB (STO:EKTAB) announced on Friday that, as of 28 February 2014, the total number of shares in the company amounted to 382,828,564, of which 14,250,000 are A-shares and 368,578,564 are B-shares.
Elekta revises outlook for fiscal year 2013/14
M2 - Mon Feb 24, 5:52AM CST
Swedish radiation therapy company Elekta AB (STO:EKTAB.ST) reported on Friday EBITA of SEK340m for Q3 of fiscal 2013/2014.
Radware Releases Defense4All, Industry-First Open SDN Security Application for OpenDaylight Project
GlobeNewswire - Tue Feb 04, 4:30AM CST
[OPEN DAYLIGHT SUMMIT] -- Radware(Nasdaq:RDWR), a leading provider of application delivery and application security solutions for virtual and cloud data centers, today announced its contribution to the OpenDaylight Project with Defense4All, the industry's first open SDN security application to be integrated into OpenDaylight.
Elekta awarded USD16m contract to deliver cancer care solutions to Iraq
M2 - Fri Jan 24, 6:36AM CST
Human care company Elekta AB (STO:EKTAB) announced today the receipt of an order from Iraq for state-of-the-art radiation therapy equipment.
Global Radiation Therapy Equipment Strategic Business Report 2018: Linear Accelerator, Treatment Planning & Radiation Therapy Simulator Analysis
M2 - Thu Jan 09, 10:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/g3kn9n/radiation_therapy#summary) has announced the addition of the "Radiation Therapy Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, Middle East and Africa, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: - Linear Accelerator - Treatment Planning Systems - Radiation Therapy Simulator The report profiles 45 companies including many key and niche players such as: - Accuray Inc. - BrainLab - Elekta AB - GE Healthcare - Hitachi America - IBA Group Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends & Issues 3. Proton Therapy - An Insight 4. Competition 5. Cancer - A Global Concern 6. Radiation Therapy: An Overview 7. Product Overview 8. Radiotherapy Accessories 9. Cancer Therapy - Epidemiology 10. Cancer Treatment - A Cost Analysis 11. New Frontiers In Radiation Therapy 12. Product Innovations/Introductions 13. Recent Industry Activity 14. Focus On Select Key Players 15. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East And Africa 7. Latin America IV. Competitive Landscape Total Companies Profiled: 45 (including Divisions/Subsidiaries - 54) - The United States (24) - Canada (3) - Japan (4) - Europe (19) - - France (1) - - Germany (6) - - The United Kingdom (1) - - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (2) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/g3...py#summary
Elekta awarded USD28m order to provide cancer care solutions to China
M2 - Fri Jan 03, 5:56AM CST
Human care company Elekta AB (STO:EKTAB) announced on Thursday the receipt of an order by China's Health Department of the People's Liberation Army (PLA) of a comprehensive range of its clinical solutions for managing cancer.
Elekta's Versa HD system boosts radiotherapy speed and precision in first patient treatments at clinic in Germany
M2 - Fri Dec 27, 5:03AM CST
Human care company Elekta AB (STO:EKTAB.ST) announced on Thursday that on 28 October 2013, clinicians at Evangelische Kliniken Gelsenkirchen (Gelsenkirchen, Germany) launched a new era of radiation therapy speed and accuracy with its first Versa HD case, a 72-year-old female patient with advanced (metastatic) cancer.
Brachytherapy Devices Worldwide Market Report 2013-2016
M2 - Fri Nov 01, 6:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/52pl6c/global) has announced the addition of the "Brachytherapy Devices Worldwide Market Report 2013-2016" report to their offering. Analysts forecast the brachytherapy devices market to grow at a CAGR of 2.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant increase in the number of cancer patients worldwide. The Global Brachytherapy Devices market has also been witnessing a significant increase in the number of acquisitions. However, alternatives for cancer treatment could pose a challenge to the growth of this market. The report, Brachytherapy Devices Worldwide Market Report 2013-2016, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Brachytherapy Devices market landscape and its growth prospects in the coming years. Key questions answered in this report: - What will the market size be in 2016 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? - You can request one free hour of analyst time when you purchase this report. Details provided within the report. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Key Leading Countries 7. Rate of Incidence and Prevalence 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and Their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned - Boston Scientific - C.R. Bard - CIVCO Medical Instruments - CONMED - Cook Medical - Eckert & Ziegler BEBIG - Elekta AB - GE Healthcare - Gammex - Huiheng Medical - Olympus - Theragenics - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/52pl6c/global
Elekta names Niklas Savander as new President and CEO
M2 - Fri Oct 25, 5:53AM CDT
Human care company Elekta AB (STO:EKTAB) announced today the appointment of Niklas Savander as the company's president and chief executive officer, effective 1 May 2014.
Elekta Nomination Committee's proposed Board of Directors for 2014 Annual General Meeting
Business Wire - 55 mins ago
Regulatory News:
Global Laboratory Information Systems (LIS / LIMS) Market 2017 - Clinical Laboratory Software and Hardware, Drug Discovery Systems
M2 - Wed Apr 16, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/644b9v/laboratory) has announced the addition of the "Laboratory Information Systems (LIS / LIMS) Markets - Clinical Laboratory Software and Hardware, Drug Discovery Systems" report to their offering. The market for laboratory information management systems will grow to nearly a $1.5 billion market in 2015. The healthcare market research firm said growth would be spurred on by the desire of clinical diagnostic laboratories to handle larger amounts of data from molecular testing and sequencing. Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories. The World Market for Lab Information Systems (LIS) analyzes the current and potential world markets for medical laboratory information system software and hardware - both for the clinical diagnostics lab and the drug discovery and research laboratory. This report forecasts future growth to 2017. Market segments covered include the world, North American, European, Brazilian and Japanese markets, as well as segments for LIS software and hardware. As part of its coverage, the report contains the following: - Clinical LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Drug Discovery LIMS Market in North America, Europe, Brazil, Japan, Rest of World - Recent Key Mergers and Acquisitions - Laboratory Types and Growth - Laboratory Information Systems Selected Vendors, Approximate Number of Contracts/Operating Sites - Software Markets - Hardware Markets - Service Markets - Drivers and Obstacles to Growth This report also reviews the nature and direction of research and trends, and gives insight into some issues facing the industry. Among these trends are the following: - Accelrys Acquires Aegis, Vialis - Roper Acquires Sunquest - StarLims Acquires Distributors - On-Demand LIMS - Toxicology LIS - HIPAA 5010 Migration - Multi-Groups Capability - Middleware Platform - Cerner Expands with Labotix Acquisition - Next-Generation Sequencing - Proof of Concept Service Key Topics Covered: Chapter One: Executive Summary Chapter Two: Introduction Chapter Three: Trends And Issues Chapter Four: Recent Market Developments Chapter Five: Markets Chapter Six: Corporate Profiles - AAC Infotray AG - Accelrys Inc - Accelerated Technology Laboratories Inc - AJ Blomesystem GmbH - ASM Soft SL - Autoscribe - CambridgeSoft - Cerner Corp - ChemWare Inc - Clinical Software Solutions - Data Unlimited International Inc. - Desarrollo Aplicaciones Sanitarias SL - eBioSys Pty Ltd - Elekta AB - Kriti Microsystems Pvt. Ltd - LabLogic Systems Ltd - LabVantage Solutions Inc - LabWare Inc - LIMS at Work GmbH - McKesson Technology Solutions - Modul-Bio - Orchard Software Corp - PathCentral - Polisystem Informatica Srl - Siemens Healthcare - Swisslab GmbH - Tainosystems - Technidata - Thermo Fisher Scientific - Visual Access Health Systems Pvt. Ltd For more information visit http://www.researchandmarkets.com/research/644b9v/laboratory
Global Radiation Therapy Equipment Market 2014-2018: Key Regions, Key Vendors and Key Market Trends
M2 - Wed Mar 26, 5:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v2bjnr/global_radiation) has announced the addition of the "Global Radiation Therapy Equipment Market 2014-2018" report to their offering. Radiation therapy equipment is used to perform radiation therapy, also known as radiotherapy or radiation oncology, which is a procedure used in the treatment of cancer. It involves delivering high doses of radiation consisting of photons, electrons or gamma rays to kill cancer cells and reduce the rate at which the cancerous cells multiply by damaging the DNA inside the tumor cells. Radiation therapy is used to treat cancers of the head and neck, bladder, and lung as well as Hodgkin's disease. Radiation therapy can be administered in several ways. The type of therapy prescribed by oncologists depends on factors such as the type of cancer, the stage of the cancer, the size of the tumor, the position of the tumor in the body, the age of the patient, and the patient's medical history. Radiation therapy can either be given independently or in conjunction with other cancer treatments such as surgery and chemotherapy. The analysts forecast the Global Radiation Therapy Equipment market will grow at a CAGR of 6.04 percent over the period 2013-2018. Key Regions - Americas - EMEA - APAC Key Vendors - Accuray Inc. - Elekta AB - Siemens Healthcare - Varian Medical Systems Inc. Other Prominent Vendors - Best Theratronics Ltd. - Brainlab AG - C.R. Bard Inc. - Eckert & Ziegler BEBIG - GE Healthcare Ltd. - Hitachi America Ltd. - Ion Beam Applications SA - Philips Healthcare - RaySearch Laboratories AB Key Market Drivers - Increase in Aging Population. - For a full, detailed list, view our report. For more information visit http://www.researchandmarkets.com/research/v2..._radiation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Internal Beam & Systemic Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017
M2 - Wed Mar 12, 3:53AM CDT
Research and Markets (http://www.researchandmarkets.com/research/t7wqw3/internal_beam_and) has announced the addition of the "Internal Beam & Systemic Radiation Therapy Devices Market Assessment Report - Global Size, Share, Competitive Landscape, Future Prospects and Forecast from 2013-2017" report to their offering. Rising cancer cases have made radiotherapy a standard procedure for oncology treatment. With a prominent rise in their GDP, emerging nations act as the future growth opportunities for the global radiotherapy market. Internal radiation therapy or brachytherapy is one of the oldest techniques for the treatment of cancerous tumors. As per the procedures, this process is categorized into permanent and temporary procedures where low dose rate and high dose rate brachytherapy are applied respectively. This report comprises of a holistic analysis of the market in terms of forces affecting the market. Its sub-components/forces include bargaining power of suppliers, bargaining power of buyers, threat of substitutes, threat of new entrants and competitive rivalry. The study analyzes the market for segments such as brachytherapy seeds, applicators and afterloaders and electronic brachytherapy along with their applications that include Prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, lung cancer, head and neck cancer and esophageal cancer. The study also analyzes four regions namely, North America, Europe, Asia-Pacific and Rest of the World for the Internal Beam Radiation Devices Market. The report elucidates several dynamics of the market such as the drivers, inhibitors, and opportunities that are illustrated throughout the report. It provides current and future outlook for the market on a global level as well as a focused view on independent sub-segments within the market. The report also profiles key market players Accuray Inc., Angiodynamics Inc., Boston Scientific Corporation, C.R. Bard, Cardinal Health Inc., Covidien PLC, GE Healthcare, Siemens Healthcare, Theragenics Corporation and others. The study provides a market share analysis for the year 2012 with respect to key players and also provides recent developments for all profiled companies. Key Topics Covered - Introduction to the Report - Market Synopsis - Market Dynamics - Products Market Size & Forecast - Global Internal Beam Radiation Therapy Devices - Products Market Size & Forecast - Global Systemic Radiation Therapy Devices - Applications Market Size & Forecast - Global Internal Beam Radiation and Systemic Therapy Devices - Technology Market Size & Forecast - Global Internal Beam Radiation Therapy Devices - Geography Market Size & Forecast - Global Internal Beam & Systemic Radiation Therapy Devices - Competitive Scenario: Key Players - Company Profiles Companies Mentioned - Boston Scientific - C.R. Bard - Eckert & Ziegler BEBIG - Elekta AB - GE Healthcare - IBA - Nordion - Theragenics - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/t7...l_beam_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Elekta reports number of share
M2 - Mon Mar 03, 4:26AM CST
Human care company Elekta AB (STO:EKTAB) announced on Friday that, as of 28 February 2014, the total number of shares in the company amounted to 382,828,564, of which 14,250,000 are A-shares and 368,578,564 are B-shares.
Elekta revises outlook for fiscal year 2013/14
M2 - Mon Feb 24, 5:52AM CST
Swedish radiation therapy company Elekta AB (STO:EKTAB.ST) reported on Friday EBITA of SEK340m for Q3 of fiscal 2013/2014.
Radware Releases Defense4All, Industry-First Open SDN Security Application for OpenDaylight Project
GlobeNewswire - Tue Feb 04, 4:30AM CST
[OPEN DAYLIGHT SUMMIT] -- Radware(Nasdaq:RDWR), a leading provider of application delivery and application security solutions for virtual and cloud data centers, today announced its contribution to the OpenDaylight Project with Defense4All, the industry's first open SDN security application to be integrated into OpenDaylight.
Elekta awarded USD16m contract to deliver cancer care solutions to Iraq
M2 - Fri Jan 24, 6:36AM CST
Human care company Elekta AB (STO:EKTAB) announced today the receipt of an order from Iraq for state-of-the-art radiation therapy equipment.
Global Radiation Therapy Equipment Strategic Business Report 2018: Linear Accelerator, Treatment Planning & Radiation Therapy Simulator Analysis
M2 - Thu Jan 09, 10:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/g3kn9n/radiation_therapy#summary) has announced the addition of the "Radiation Therapy Equipment - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, Middle East and Africa, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: - Linear Accelerator - Treatment Planning Systems - Radiation Therapy Simulator The report profiles 45 companies including many key and niche players such as: - Accuray Inc. - BrainLab - Elekta AB - GE Healthcare - Hitachi America - IBA Group Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends & Issues 3. Proton Therapy - An Insight 4. Competition 5. Cancer - A Global Concern 6. Radiation Therapy: An Overview 7. Product Overview 8. Radiotherapy Accessories 9. Cancer Therapy - Epidemiology 10. Cancer Treatment - A Cost Analysis 11. New Frontiers In Radiation Therapy 12. Product Innovations/Introductions 13. Recent Industry Activity 14. Focus On Select Key Players 15. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East And Africa 7. Latin America IV. Competitive Landscape Total Companies Profiled: 45 (including Divisions/Subsidiaries - 54) - The United States (24) - Canada (3) - Japan (4) - Europe (19) - - France (1) - - Germany (6) - - The United Kingdom (1) - - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (2) - Latin America (1) - Africa (1) For more information visit http://www.researchandmarkets.com/research/g3...py#summary
Elekta awarded USD28m order to provide cancer care solutions to China
M2 - Fri Jan 03, 5:56AM CST
Human care company Elekta AB (STO:EKTAB) announced on Thursday the receipt of an order by China's Health Department of the People's Liberation Army (PLA) of a comprehensive range of its clinical solutions for managing cancer.
Elekta's Versa HD system boosts radiotherapy speed and precision in first patient treatments at clinic in Germany
M2 - Fri Dec 27, 5:03AM CST
Human care company Elekta AB (STO:EKTAB.ST) announced on Thursday that on 28 October 2013, clinicians at Evangelische Kliniken Gelsenkirchen (Gelsenkirchen, Germany) launched a new era of radiation therapy speed and accuracy with its first Versa HD case, a 72-year-old female patient with advanced (metastatic) cancer.
Brachytherapy Devices Worldwide Market Report 2013-2016
M2 - Fri Nov 01, 6:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/52pl6c/global) has announced the addition of the "Brachytherapy Devices Worldwide Market Report 2013-2016" report to their offering. Analysts forecast the brachytherapy devices market to grow at a CAGR of 2.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant increase in the number of cancer patients worldwide. The Global Brachytherapy Devices market has also been witnessing a significant increase in the number of acquisitions. However, alternatives for cancer treatment could pose a challenge to the growth of this market. The report, Brachytherapy Devices Worldwide Market Report 2013-2016, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Brachytherapy Devices market landscape and its growth prospects in the coming years. Key questions answered in this report: - What will the market size be in 2016 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? - What are the market opportunities and threats faced by the key vendors? - What are the strengths and weaknesses of the key vendors? - You can request one free hour of analyst time when you purchase this report. Details provided within the report. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Key Leading Countries 7. Rate of Incidence and Prevalence 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and Their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 16. Other Reports in this Series Companies Mentioned - Boston Scientific - C.R. Bard - CIVCO Medical Instruments - CONMED - Cook Medical - Eckert & Ziegler BEBIG - Elekta AB - GE Healthcare - Gammex - Huiheng Medical - Olympus - Theragenics - Varian Medical Systems For more information visit http://www.researchandmarkets.com/research/52pl6c/global
Elekta names Niklas Savander as new President and CEO
M2 - Fri Oct 25, 5:53AM CDT
Human care company Elekta AB (STO:EKTAB) announced today the appointment of Niklas Savander as the company's president and chief executive officer, effective 1 May 2014.
